Serial 88270786
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Jul 2025)
What this means for you
Registered since 13 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88270786
- Registration number
- 5833580
- Mark type
- Design / logo
- Filed
- 22 Jan 2019
- Published for opposition
- 23 Apr 2019
- Registered
- 13 Aug 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and related symptoms
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 12 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Jul 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 8 & 15 RECEIVED
- 13 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2019 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 25 Jun 2019 — NOTICE OF ALLOWANCE CANCELLED
- 11 Jul 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jun 2019 — TEAS DELETE 1(B) BASIS RECEIVED
- 18 Jun 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2019 — PUBLISHED FOR OPPOSITION
- 03 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED